120 related articles for article (PubMed ID: 24232915)
61. An assay for detecting neutralization of rotavirus infection by quantitative determination of VP6 protein fluorescence intensity.
Xijier ; Inagaki M; Kishita K; Yabe T; Kanamaru Y
Biosci Biotechnol Biochem; 2011; 75(10):2059-62. PubMed ID: 21979094
[TBL] [Abstract][Full Text] [Related]
62. Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes.
Wolf M; Vo PT; Greenberg HB
J Virol; 2011 Mar; 85(6):2492-503. PubMed ID: 21191022
[TBL] [Abstract][Full Text] [Related]
63. A novel method for the in vitro assembly of virus-like particles and multimeric proteins.
Rodríguez M; Castro-Acosta RM; Ruiz-Morales ER; Villanueva-Flores F; Ramírez OT; Palomares LA
Biotechnol Lett; 2021 Jun; 43(6):1155-1161. PubMed ID: 33638746
[TBL] [Abstract][Full Text] [Related]
64. Production of in vivo-biotinylated rotavirus particles.
De Lorenzo G; Eichwald C; Schraner EM; Nicolin V; Bortul R; Mano M; Burrone OR; Arnoldi F
J Gen Virol; 2012 Jul; 93(Pt 7):1474-1482. PubMed ID: 22442113
[TBL] [Abstract][Full Text] [Related]
65. The tyrosine kinase inhibitor genistein induces the detachment of rotavirus particles from the cell surface.
López T; López S; Arias CF
Virus Res; 2015 Dec; 210():141-8. PubMed ID: 26216271
[TBL] [Abstract][Full Text] [Related]
66. Rotavirus VP6 modified for expression on the plasma membrane forms arrays and exhibits enhanced immunogenicity.
Reddy DA; Bergmann CC; Meyer JC; Berriman J; Both GW; Coupar BE; Boyle DB; Andrew ME; Bellamy AR
Virology; 1992 Aug; 189(2):423-34. PubMed ID: 1322583
[TBL] [Abstract][Full Text] [Related]
67. Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry.
Aoki ST; Trask SD; Coulson BS; Greenberg HB; Dormitzer PR; Harrison SC
J Virol; 2011 Oct; 85(20):10509-17. PubMed ID: 21849465
[TBL] [Abstract][Full Text] [Related]
68. Antigenicity and immunogenicity of rotavirus VP6 protein expressed on the surface of Lactococcus lactis.
Esteban LE; Temprana CF; Argüelles MH; Glikmann G; Castello AA
Biomed Res Int; 2013; 2013():298598. PubMed ID: 23984337
[TBL] [Abstract][Full Text] [Related]
69. Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate.
Kato T; Kakuta T; Yonezuka A; Sekiguchi T; Machida Y; Xu J; Suzuki T; Park EY
Mol Biotechnol; 2023 Mar; 65(3):401-409. PubMed ID: 35963985
[TBL] [Abstract][Full Text] [Related]
70. Differential accessibility of a rotavirus VP6 epitope in trimers comprising type I, II, or III channels as revealed by binding of a human rotavirus VP6-specific antibody.
Aiyegbo MS; Eli IM; Spiller BW; Williams DR; Kim R; Lee DE; Liu T; Li S; Stewart PL; Crowe JE
J Virol; 2014 Jan; 88(1):469-76. PubMed ID: 24155406
[TBL] [Abstract][Full Text] [Related]
71. A zinc ion controls assembly and stability of the major capsid protein of rotavirus.
Erk I; Huet JC; Duarte M; Duquerroy S; Rey F; Cohen J; Lepault J
J Virol; 2003 Mar; 77(6):3595-601. PubMed ID: 12610135
[TBL] [Abstract][Full Text] [Related]
72. High-dimensional immune profiling of total and rotavirus VP6-specific intestinal and circulating B cells by mass cytometry.
Nair N; Newell EW; Vollmers C; Quake SR; Morton JM; Davis MM; He XS; Greenberg HB
Mucosal Immunol; 2016 Jan; 9(1):68-82. PubMed ID: 25899688
[TBL] [Abstract][Full Text] [Related]
73. Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins.
Lappalainen S; Vesikari T; Blazevic V
Arch Virol; 2016 Nov; 161(11):3219-23. PubMed ID: 27518400
[TBL] [Abstract][Full Text] [Related]
74. Structural correlates of rotavirus cell entry.
Abdelhakim AH; Salgado EN; Fu X; Pasham M; Nicastro D; Kirchhausen T; Harrison SC
PLoS Pathog; 2014 Sep; 10(9):e1004355. PubMed ID: 25211455
[TBL] [Abstract][Full Text] [Related]
75. Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials.
Shoja Z; Jalilvand S; Latifi T; Roohvand F
Arch Virol; 2022 Apr; 167(4):1013-1023. PubMed ID: 35292854
[TBL] [Abstract][Full Text] [Related]
76. Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only.
Heinimäki S; Tamminen K; Hytönen VP; Malm M; Blazevic V
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32645976
[TBL] [Abstract][Full Text] [Related]
77. Transient Expression in Cytoplasm and Apoplast of Rotavirus VP6 Protein Fused to Anti-DEC205 Antibody in Nicotiana benthamiana and Nicotiana sylvestris.
Castillo-Esparza JF; Gómez-Lim MA
Mol Biotechnol; 2021 Oct; 63(10):973-982. PubMed ID: 34146324
[TBL] [Abstract][Full Text] [Related]
78. Characterization of conductive nanobiomaterials derived from viral assemblies by low-voltage STEM imaging and Raman scattering.
Plascencia-Villa G; Carreño-Fuentes L; Bahena D; José-Yacamán M; Palomares LA; Ramírez OT
Nanotechnology; 2014 Sep; 25(38):385706. PubMed ID: 25180475
[TBL] [Abstract][Full Text] [Related]
79. Modulating the physicochemical and structural properties of gold-functionalized protein nanotubes through thiol surface modification.
Carreño-Fuentes L; Plascencia-Villa G; Palomares LA; Moya SE; Ramírez OT
Langmuir; 2014 Dec; 30(49):14991-8. PubMed ID: 25409000
[TBL] [Abstract][Full Text] [Related]
80. Cell lines susceptible to infection are permeabilized by cleaved and solubilized outer layer proteins of rotavirus.
Ruiz MC; Abad MJ; Charpilienne A; Cohen J; Michelangeli F
J Gen Virol; 1997 Nov; 78 ( Pt 11)():2883-93. PubMed ID: 9367375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
